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Experience with polymethylmethacrylate 30% (PMMA) facial
filling in patients with facial HIV lipoatrophy using of local
anesthesia dentistry
Matsuda, E; Soares, F and Brigido, L
Santo Andre ´ Aids Program, Santo Andre ´, Brazil.
Background
HIV-associated lipoatrophy in a common and stigmatizing side effect of HIV infection, is aggravated by antiretroviral therapy; its
presence causes distress and compromises adherence to therapy. PMMA filling is often associated with pain and discomfort.
Objective
To evaluate outpatient intervention using local dentistry anesthesia.
Methods
Patients complaining of facial lipoatrophy, from 10/2007 to 11/2011, were offered the filling with PMMA. Cases with bleeding
potential, acute or decompensated chronic diseases or use of immunosuppressors or chemotherapy were excluded. Inclusion
criteria: perception of distressing malar lipoatrophy and both the assisting physician and the applicant agreeing with potential
benefit. After informed consent, patients were infused with 30 mg prilocaine/0.03 IU felypressin in 1.8 ml, using a carpule type
syringe aiming to block the posterior superior alveolar nerve. This was followed by PMMA infiltration in different points at
the malar region. At first return a simple questionnaire evaluating pain, satisfaction, grading 0 to 10 and if would repeat the
procedure.
Results
All 64 eligible patients were included. Mean age 46 (13 to 73) years, mostly white (71.87%), males (68.75%), 37.5% of them
MSM. Arterial hypertension was the most prevalent comorbidity (17%), 78% with viral load B50 c/mL, with a median 585 CD4
cells/mL (952063). On a median of 8 years on treatment, 1/3 had been exposed to three classes (NRTI/ NNRTI/PI), one
antiretroviral-naı ¨ve. Of the 12 patients who had detectable viral load in the first procedure, seven were suppressed to below 50
copies/mL during follow up. Two of the five patients remaining with detectable viremia died from other causes, 2 transferred
and 1 remained naı ¨ve. 127 procedures were made in 64 patients, a median of 2 (16) per patient. After a mean follow-up of
33 weeks, no infection or late complications were observed. Mean dispensed volume was 9 mL (1.5 to 22). Pain grade was
documented in 105 procedures; grade B4 reported by 46%, 46 by 34%; 78 by 16%, 9 by 2%. All reported that the pain would
not hamper future procedures; 94% refer an overall satisfaction from 8 to 10.
Conclusion
The use of local anesthesia in dental facial filling with PMMA in patients with HIV lipoatrophy of the face is safe, decreases pain
to tolerable levels and allows high levels of satisfaction with the procedure. The procedure may improve patient adherence to
ARV.
Published 11 November 2012
Copyright: – 2012 Matsuda E et al; licensee International AIDS Society. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Abstracts of the Eleventh International Congress on Drug Therapy in HIV Infection
Matsuda E et al. Journal of the International AIDS Society 2012, 15(Suppl 4):18307
http://www.jiasociety.org/index.php/jias/article/view/18307 | http://dx.doi.org/10.7448/IAS.15.6.18307
1